期刊
HAUTARZT
卷 56, 期 12, 页码 1144-+出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00105-005-0953-2
关键词
atopic eczema; cost-of-illness study; disease severity
类别
Background. Atopic eczema is one of the most common skin diseases. In Germany, the economic burden is estimated to be EUR 1.2-3.5 billion yearly. The aim of this study was to show the resource utilization and costs for outpatient care and the out-of-pocket expenses for the patients. Patients and methods. This study was a multi-center, retrospective and prospective cost-of-illness study. Patient characteristics and data on resource utilization were collected with a semi-structured patient questionnaire and by chart abstraction. 193 patients filled in the patient questionnaire; data from 169 patients were obtained by chart abstraction. Results. Average direct medical costs of a disease flare were EUR 123 per patient. Average annual total costs were EUR 1,425 per patient, increasing with severity from EUR 956 (mild) to EUR 2,068 (severe). Conclusion. Prolongation of flare-free time and reduction in severity are not only desirable for the patients but also of economic interest.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据